化合物C通过AMPK独立途径对Graves轨道病产生治疗作用
Hyun Young Park1, Soo Hyun Choi1, Hyeon Seo Lee2
1Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
International journal of molecular medicine
|March 21, 2025
概括
化合物C有效地通过抑制轨道纤维细胞中的炎症,纤维化和脂肪生成来治疗格雷夫斯轨道病. 这种治疗效果是通过一种新的,与腺单酸激活蛋白激酶 (AMPK) 独立的途径实现的,该途径涉及对相关蛋白 (YAP) 失活.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 细胞生物学 细胞生物学
背景情况:
- 格雷夫斯轨道病 (GO) 是一种影响轨道组织的自身免疫性疾病,导致炎症,纤维化和脂肪生成.
- 已知酶抑制剂的化合物C已经证明具有抗增殖作用,但其在GO中的治疗潜力超出AMPK抑制需要研究.
研究的目的:
- 为了研究高度的化合物C对人类轨道纤维细胞中Graves轨道病变 (GO) 发病的治疗作用.
- 阐明YAP信号通路在化合物C对GO炎症,纤维化和脂肪生成的影响中的作用.
主要方法:
- 来自GO患者和健康对照组的初级轨道纤维细胞被培养并用化合物C处理.
- 用IL-1β或TGF-β刺激细胞,并评估了包括促炎性细胞因子表达,益纤维蛋白生产,脂肪生成 (油红色O染色) 和氨酸分泌的反应.
- 西方涂抹被用于评估蛋白质酸化 (AMPK,YAP,Akt,SMAD1/2/3),并对YAP进行了敲除,以评估其在脂肪生成中的作用.
主要成果:
- 化合物C (10μM) 在轨道纤维细胞中显著抑制AMPK和YAP酸化.
- 化合物C抑制了IL-1β诱导的益炎性细胞因子的产生,TGF-β诱导的益纤维蛋白的产生,以及氨酸的分泌.
- YAP的淘汰效应模仿了化合物C的作用,显著减弱了脂肪生成和脂肪生成标记物的产生,这表明YAP的失活会调解这些效应.
结论:
- 化合物C通过一种腺单酸激活蛋白激酶 (AMPK) 独立的机制,对格雷夫斯轨道病产生治疗作用.
- 化合物C抑制了轨道纤维细胞中的炎症,纤维化和脂肪生成,可能通过对YAP信号通路的失活.
- 这些发现表明,化合物C是针对多种致病途径的潜在治疗剂,可以治疗格雷夫斯轨道病变.
相关概念视频
GPCRs Regulate Adenylyl Cylase Activity
5.1K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.1K
cAMP-dependent Protein Kinase Pathways
6.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K
GPCR Desensitization
5.7K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.7K
Antiepileptic Drugs: GABAergic Pathway Potentiators
303
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
303
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.1K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.1K
G-Protein Gated Ion Channels
4.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.5K


